Frontiers in Pharmacology | Cardiovascular and Smooth Muscle Pharmacology

Editorial

Published on 10 Feb 2025

Editorial: Exploring small molecule inhibitors in cardiovascular and cerebrovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Basveshwar Gawali
Shweta Shrivastava
R. Uday Kumar
Satyendra Kumar Rajput
Manish Kumar Jeengar

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559488

465 views

Review

Accepted on 06 Feb 2025

Acacetin as a Natural Cardiovascular Therapeutic: Mechanisms and Preclinical Evidence

in Cardiovascular and Smooth Muscle Pharmacology

Zihe Zhou
Tao Li
Helin Qin
Xinyu Wang
Shanshan He
Zhongcai Fan
Qiang Ye
Yanfei Du

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1493981

Review

Published on 06 Feb 2025

Role of ferroptosis in atrial fibrillation: a review

in Cardiovascular and Smooth Muscle Pharmacology

Shaowei Fan
Yuanhui Hu
Jingjing Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1362060

844 views

Review

Published on 05 Feb 2025

The interplay of ferroptosis and oxidative stress in the pathogenesis of aortic dissection

in Cardiovascular and Smooth Muscle Pharmacology

Zhaoshan Zhang
Haichao Wang
Xi Kan
Xiaozhao Zhang
Senping Xu
Jie Cai
Jiawei Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1519273

712 views

Original Research

Published on 31 Jan 2025

Mechanism of mTOR/RILP-regulated autophagic flux in increased susceptibility to myocardial ischemia-reperfusion in diabetic mice

in Cardiovascular and Smooth Muscle Pharmacology

Jiyao Zhao
Wei Shi
Yan Zheng
Junjie Wang
Muzhao Yuan
Yultuz Anwar
Yuxuan He
Haiping Ma
Jianjiang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1506401

639 views

Original Research

Published on 30 Jan 2025

Mechanism of salvianolic phenolic acids and hawthorn triterpenic acids combination in intervening atherosclerosis: network pharmacology, molecular docking, and experimental validation

in Cardiovascular and Smooth Muscle Pharmacology

Qu Zhai
Shixi Shang
Zihan Zhang
Lihua Sun
Ying Huang
Shuyi Feng
Qian Wu
Haifeng Cui
Xiaolu Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1501846

769 views

Case Report

Published on 29 Jan 2025

From the right ventricle to the descending aorta: a Case Report of complex thrombotic events in a patient with nephrotic syndrome

in Cardiovascular and Smooth Muscle Pharmacology

Jiaojiao Chen
Longyin Zhu
Fen Zhou
Yuting Li
Tao Gu
Jing Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1514801

570 views

Original Research

Published on 27 Jan 2025

Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation

in Cardiovascular and Smooth Muscle Pharmacology

Ai-Li Xu
Zheng Shen
Shi-Hao Wang
Hai-Yun Luan
Yong Xu
Ze-Chun Kang
Zi-Qi Liao
Jie Liu
Xiao-Lei Duan
Wei-Hua Bian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1496380

474 views

Original Research

Published on 27 Jan 2025

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system

in Cardiovascular and Smooth Muscle Pharmacology

Jingrong Yang
Mengfan You
Jingxin Wang
Rongfei Sun
Lili Han
Xiaonan Liu
Kaibin Niu
Kaidi Xing
Juanping Sun
Wenge Su

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1517616

661 views

Correction

Published on 22 Jan 2025

Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling

in Cardiovascular and Smooth Muscle Pharmacology

Bin Zhang
Jingyi Zhang
Chenyang Zhang
Xuelian Zhang
Jingxue Ye
Shihuan Kuang
Guibo Sun
Xiaobo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488083

419 views

Original Research

Published on 15 Jan 2025

Drug-induced heart failure: a real-world pharmacovigilance study using the FDA adverse event reporting system database

in Cardiovascular and Smooth Muscle Pharmacology

Youqi Huang
Xiaowen Chen
Mingyu Chen
Yuze Lin
Bingqi Chen
Hongjin Gao
Min Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1523136

902 views

Original Research

Published on 15 Jan 2025

Effect of prophylactic doses of enoxaparin on antifactor Xa activity confirmed by rotational thromboelastometry in critically ill patients: a preliminary prospective cohort study

in Cardiovascular and Smooth Muscle Pharmacology

Piotr F. Czempik
Artur Beberok

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498188

471 views

Original Research

Published on 13 Jan 2025

Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization

in Cardiovascular and Smooth Muscle Pharmacology

Min Lu
Jiaqi Li
Huanyu Ni
Tong Qiao
Baoyan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485380

574 views

Original Research

Published on 10 Jan 2025

Assembly of ceria-Nrf2 nanoparticles as macrophage-targeting ROS scavengers protects against myocardial infarction

in Cardiovascular and Smooth Muscle Pharmacology

Wenjing Liao
Jinduan Lin
Wenli Wang
Ming Zhang
Yanfang Chen
Xin Li
Huan Liu
Pan Xia Wang
Guojun Zhao
Jijun Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503757

743 views

Review

Published on 10 Jan 2025

Interplay between energy metabolism and NADPH oxidase-mediated pathophysiology in cardiovascular diseases

in Cardiovascular and Smooth Muscle Pharmacology

Haipeng Jie
Jingjing Zhang
Shuzhen Wu
Luyao Yu
Shengnan Li
Bo Dong
Feng Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503824

1,042 views

Original Research

Published on 07 Jan 2025

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis

in Cardiovascular and Smooth Muscle Pharmacology

Aleksandra Antonczyk
Katarzyna Kluzek
Natalia Herbich
Mahdi Eskandarian Boroujeni
Bart Krist
Dorota Wronka
Anna Karlik
Lukasz Przybyl
Adam Plewinski
Joanna Wesoly

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1471182

1,142 views

Navigation group

Articles

Editorial: Exploring small molecule inhibitors in cardiovascular and cerebrovascular diseases

Acacetin as a Natural Cardiovascular Therapeutic: Mechanisms and Preclinical Evidence

Role of ferroptosis in atrial fibrillation: a review

The interplay of ferroptosis and oxidative stress in the pathogenesis of aortic dissection

Mechanism of mTOR/RILP-regulated autophagic flux in increased susceptibility to myocardial ischemia-reperfusion in diabetic mice

Mechanism of salvianolic phenolic acids and hawthorn triterpenic acids combination in intervening atherosclerosis: network pharmacology, molecular docking, and experimental validation

From the right ventricle to the descending aorta: a Case Report of complex thrombotic events in a patient with nephrotic syndrome

Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system

Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling

Drug-induced heart failure: a real-world pharmacovigilance study using the FDA adverse event reporting system database

Effect of prophylactic doses of enoxaparin on antifactor Xa activity confirmed by rotational thromboelastometry in critically ill patients: a preliminary prospective cohort study

Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization

Assembly of ceria-Nrf2 nanoparticles as macrophage-targeting ROS scavengers protects against myocardial infarction

Interplay between energy metabolism and NADPH oxidase-mediated pathophysiology in cardiovascular diseases

Identification of ALEKSIN as a novel multi-IRF inhibitor of IRF- and STAT-mediated transcription in vascular inflammation and atherosclerosis